# Dose-ranging Study of APD405 in Post-operative Nausea and Vomiting (PONV)

> **NCT00895830** · PHASE2 · COMPLETED · sponsor: **Acacia Pharma Ltd** · enrollment: 257 (actual)

## Conditions studied

- Postoperative Nausea and Vomiting

## Interventions

- **DRUG:** APD405
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00895830
- **Lead sponsor:** Acacia Pharma Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 257 (ACTUAL)
- **Last updated:** 2011-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00895830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00895830, "Dose-ranging Study of APD405 in Post-operative Nausea and Vomiting (PONV)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00895830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*